IDXX vs YCBD · P/E 40, rev $2.36B vs P/E 0.3, rev $16.2M
IDEXX Laboratories Inc (IDXX) versus cbdMD Inc (YCBD) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
cbdMD Inc (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported YCBD revenue for 2026-06-30 was $16.2M. Net income was -$2.2M. Revenue was up 52.1% from 2026-03-31 to 2026-06-30. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
Not investment advice. Open the IDXX and YCBD stock pages for the full models.
Not investment advice.